Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

Clinical trial NCT05728736 · WITHDRAWN

Trial details

NCT number: NCT05728736
Sponsor: Brendan Lucey
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-03-01
Primary completion: 2023-09-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.